Cargando…
Perspective: Cell therapy, SARS‐CoV‐2, COVID‐19, and James Lind
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273049/ https://www.ncbi.nlm.nih.gov/pubmed/32838211 http://dx.doi.org/10.1002/acg2.88 |
| _version_ | 1783542329328533504 |
|---|---|
| author | Gale, Robert P. |
| author_facet | Gale, Robert P. |
| author_sort | Gale, Robert P. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7273049 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-72730492020-06-05 Perspective: Cell therapy, SARS‐CoV‐2, COVID‐19, and James Lind Gale, Robert P. Adv Cell Gene Ther Expert Perspectives John Wiley and Sons Inc. 2020-05-21 2020-10 /pmc/articles/PMC7273049/ /pubmed/32838211 http://dx.doi.org/10.1002/acg2.88 Text en © 2020 The Authors. Advances in Cell and Gene Therapy published by John Wiley & Sons Ltd https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Expert Perspectives Gale, Robert P. Perspective: Cell therapy, SARS‐CoV‐2, COVID‐19, and James Lind |
| title | Perspective: Cell therapy, SARS‐CoV‐2, COVID‐19, and James Lind |
| title_full | Perspective: Cell therapy, SARS‐CoV‐2, COVID‐19, and James Lind |
| title_fullStr | Perspective: Cell therapy, SARS‐CoV‐2, COVID‐19, and James Lind |
| title_full_unstemmed | Perspective: Cell therapy, SARS‐CoV‐2, COVID‐19, and James Lind |
| title_short | Perspective: Cell therapy, SARS‐CoV‐2, COVID‐19, and James Lind |
| title_sort | perspective: cell therapy, sars‐cov‐2, covid‐19, and james lind |
| topic | Expert Perspectives |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273049/ https://www.ncbi.nlm.nih.gov/pubmed/32838211 http://dx.doi.org/10.1002/acg2.88 |
| work_keys_str_mv | AT galerobertp perspectivecelltherapysarscov2covid19andjameslind |